Patents by Inventor Fabien AUDIBERT

Fabien AUDIBERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11213539
    Abstract: The present invention relates to a combination of ivermectin and brimonidine for use in the treatment and/or the prevention of moderate to severe rosacea, preferably by topical administration of a 1% ivermectin cream and 0.33% brimonidine gel.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: January 4, 2022
    Assignee: GALDERMA HOLDING SA
    Inventors: Philippe Martel, Nabil Kerrouche, Fabien Audibert
  • Publication number: 20180344757
    Abstract: The present invention relates to a combination of ivermectin and brimonidine for use in the treatment and/or the prevention of moderate to severe rosacea, preferably by topical administration of a 1% ivermectin cream and 0.33% brimonidine gel.
    Type: Application
    Filed: November 17, 2016
    Publication date: December 6, 2018
    Inventors: PHILIPPE MARTEL, NABIL KERROUCHE, FABIEN AUDIBERT
  • Publication number: 20160310512
    Abstract: A therapy regimen is described for the treatment of severe acne related diseases preferentially severe or nodular acne. The therapy regimen adds a topical fixed-dose combination of a retinoid and an anti-bacterial agent, such as benzoyl peroxide, to a course of oral antibiotic therapy using a daily dose of antibiotic ranging from 150 mg to 300 mg per day. Also described, is a fixed-dose combination of a retinoid and an anti-bacterial agent for use in the therapy regimen, and a kit suitable for implementing such therapy.
    Type: Application
    Filed: December 18, 2014
    Publication date: October 27, 2016
    Inventors: Fabien AUDIBERT, Nabil KERROUCHE, Pascale SOTO